PATENT CLAIM ANALYSIS

Application Number: 15752896
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "210180"]

Abstract:
Provided are a substituted quinolone derivative as shown by formula (I), or a pharmaceutically acceptable salt and a prodrug molecule thereof, and a pharmaceutical composition thereof, as well as the use of same in preparing drugs for the prevention and treatment of a tumor. The quinolone derivative, salt, prodrug molecule, and pharmaceutical composition thereof can be used as a protein kinase inhibitor, which is effective in inhibiting the activity of AXL protein kinase, and is capable of inhibiting the proliferation, migration and invasion of various tumor cells; and can be used in the preparation of anti-tumor drugs, especially drugs for treating hyperproliferative diseases such as a tumor in human beings and other mammals.

Claim (Index 9):
Use of the substituted quinolone derivative, or a pharmaceutically acceptable salt or a stereoisomer thereof according to  claim 1 , or the prodrug molecule thereof in preparing drugs for the treatment or prevention of a tumor.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 88.0
- Lexical Diversity: 1.88235
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14411515', '14207868', '13928696', '13294303', '14916177']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8329759877296359
- 35 USC 102 Novelty (BERT): 0.5515582433889393
- Combined Prediction Score: 0.8048342132955661
- Mean Citation Score: 423.024436
- Max Citation Score: 440.52917
- Similarity Product: 284.20356298087535

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test